ESC 365 - Dual antiplatelet therapy versus oral anticoagulation plus antiplatelet monotherapy in patients with acute coronary syndrome and coronary artery ectasia: OVER-TIME randomized clinical trial

ACVC Premium Access

Dual antiplatelet therapy versus oral anticoagulation plus antiplatelet monotherapy in patients with acute coronary syndrome and coronary artery ectasia: OVER-TIME randomized clinical trial

Session: Late-breaking science

Topic: Pharmacotherapy

Speaker: Doctor D. Araiza Garaygordobil (Ciudad de Mexico, MX)

Event: ESC Acute CardioVascular Care 2024

Congress Presentation

Add to my library

About the speaker

Doctor Diego Araiza Garaygordobil

Instituto Nacional de Cardiologia Ignacio Chavez, Ciudad de Mexico (Mexico)

11 presentations

4 followers

4 more presentations in this session

The basal level of inflammation during cardiogenic shock is a strong independent risk marker of mortality.

Speaker: Professor F. Roubille (Montpellier, FR)

Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome: 1 year follow-up of the TRIAGE-ACS study

Speaker: Mr J. Demandt (Eindhoven, NL)

Early left ventricular unloading or conventional approach after venoarterial extracorporeal membrane oxygenation: One-year outcomes of the EARLY-UNLOAD randomized clinical trial

Speaker: Doctor Y. Lim (Gwangju, KR)

Targeted mild hypercapnia is associated with reduced hs-Troponin T release after acute myocardial infarction and out-of-hospital cardiac arrest. A sub-study of the TAME trial.

Speaker: Doctor M. Baumann Melberg (Oslo, NO)

Access the full session

Late-breaking science

Speakers: Doctor D. Araiza Garaygordobil, Professor F. Roubille, Mr J. Demandt, Doctor Y. Lim, Doctor M. Baumann Melberg

About the event

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources